Modified Donanemab Dosing May Reduce ARIA-E Risk in Early Alzheimer's

(MedPage Today) -- Modified titration of donanemab (Kisunla) for early Alzheimer's disease significantly reduced the frequency of amyloid-related imaging abnormalities with edema and effusion (ARIA-E) compared to standard dosing, while maintaining...